A looming ‘patent cliff’ could trigger a wave of biotech mergers and acquisitions, but innovation has also been humming along and could lift some stocks.
Communicating your story to the Street
A looming ‘patent cliff’ could trigger a wave of biotech mergers and acquisitions, but innovation has also been humming along and could lift some stocks.